First trials test targeting of α-synuclein for Parkinson disease

被引：5
|
作者：
Kalia, Lorraine, V [1 ,2 ,3 ,4 ]
机构：
[1] Univ Toronto, Dept Med, Div Neurol, Toronto, ON, Canada
[2] Toronto Western Hosp, Edmond J Safra Program Parkinsons Dis, Toronto, ON, Canada
[3] Toronto Western Hosp, Morton & Gloria Shulman Movement Disorders Clin, Toronto, ON, Canada
[4] Univ Hlth Network, Krembil Res Inst, Toronto, ON, Canada
来源：
NATURE REVIEWS NEUROLOGY | 2022年 / 18卷 / 12期
关键词：
D O I：
10.1038/s41582-022-00726-6
中图分类号：
R74 [神经病学与精神病学];
学科分类号：
摘要：
In the first two phase II trials of therapies that target alpha-synuclein to treat Parkinson disease, the primary endpoints were not met. However, the limitations of these studies need to be addressed in future trials and alternative approaches to targeting alpha-synuclein should be pursued before alpha-synuclein is discounted as a target.
引用
收藏
页码：703 / 704
页数：2
相关论文
共 50 条
  • [1] First trials test targeting of α-synuclein for Parkinson disease
    Lorraine V. Kalia
    Nature Reviews Neurology, 2022, 18 : 703 - 704
  • [2] Targeting α-synuclein in Parkinson's disease
    Kapurniotu, A
    CHEMISTRY & BIOLOGY, 2004, 11 (11): : 1476 - 1478
  • [3] α-synuclein and Parkinson's disease:: the first roadblock
    Chua, Christelle En Lin
    Tang, Bor Luen
    JOURNAL OF CELLULAR AND MOLECULAR MEDICINE, 2006, 10 (04) : 837 - 846
  • [4] TARGETING α-SYNUCLEIN AGGREGATION FOR PARKINSON'S DISEASE TREATMENT
    Madine, J.
    Middleton, D. A.
    DRUGS OF THE FUTURE, 2009, 34 (08) : 655 - 663
  • [5] Therapeutics in the Pipeline Targeting α-Synuclein for Parkinson's Disease
    Jasutkar, Hilary Grosso
    Oh, Stephanie E.
    Mouradian, M. Maral
    PHARMACOLOGICAL REVIEWS, 2022, 74 (01) : 207 - 237
  • [6] Targeting α-synuclein as a therapeutic strategy for Parkinson's disease
    Lawand, Nada B.
    Saade, Nayef E.
    El-Agnaf, Omar M.
    Safieh-Garabedian, Bared
    EXPERT OPINION ON THERAPEUTIC TARGETS, 2015, 19 (10) : 1351 - 1360
  • [7] Targeting -Synuclein as a therapy for Parkinson's disease: The battle begins
    Olanow, C. Warren
    Kordower, Jeffrey H.
    MOVEMENT DISORDERS, 2017, 32 (02) : 203 - 207
  • [8] Targeting Alpha-Synuclein as a Therapy for Parkinson's Disease
    Fields, Carroll Rutherford
    Bengoa-Vergniory, Nora
    Wade-Martins, Richard
    FRONTIERS IN MOLECULAR NEUROSCIENCE, 2019, 12
  • [9] Targeting α-synuclein and c-Abl in Parkinson's disease
    Xiao, Bin
    Tan, Eng-King
    TRENDS IN MOLECULAR MEDICINE, 2023, 29 (11) : 883 - 885
  • [10] Targeting Alpha-Synuclein for the Treatment of Parkinson's Disease
    Rohn, Troy T.
    CNS & NEUROLOGICAL DISORDERS-DRUG TARGETS, 2012, 11 (02) : 174 - 179
12345